|
|
Contents |
|
|
|
Diagnosis
& Evaluation
|
|
Etiology & Pathogenesis
|
|
Overall Management
|
|
Treatment
|
|
|
|
|
Diagnosis
& Evaluation
|
|
|
|
Murphy PS, Viviers L, Abson C, Rowland IJ, Brada M, Leach
MO, Dzik-Jurasz AS
Monitoring
temozolomide treatment of low-grade glioma with proton magnetic resonance
spectroscopy
Br J Cancer. 2004 Feb 23;90(4):781-6. (Clinical Study, Abstract)
|
|
|
Etiology & Pathogenesis
|
|
|
|
Losa M, Vimercati A, Acerno S, Barzaghi RL, Mortini P, Mangili F, Terreni
MR, Santambrogio G, Giovanelli M
Correlation between clinical characteristics and
proliferative activity in patients with craniopharyngioma
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):889-92. (Laboratory
Investigation, Abstract)
|
|
Moroni I, Bugiani M, D'Incerti L, Maccagnano C,
Rimoldi M, Bissola L, Pollo B, Finocchiaro G, Uziel G
L-2-hydroxyglutaric
aciduria and brain malignant tumors: a predisposing condition?
Neurology. 2004 May 25;62(10):1882-4.(Case Report, Abstract)
|
|
|
Overall Management
|
|
|
|
D
Frappaz, O Chinot, A Bataillard, M Ben Hassel, L Capelle, S Chanalet,
M Chatel, D Figarella-Branger, Y Guegan, J Guyotat, K Hoang-Xuan, E
Jouanneau, F Keime-Guibert , C Laforêt, C Linassier, H Loiseau, JP Maire, P Menei, S Rousmans, M Sanson, MP Sunyach
Summary
version of the Standards, Options and Recommendations for the management
of adult patients with
intra-cranial glioma (2002)
Electronic
Journal of Oncology, 2003, 1, 115-128. (Review Article, Reference &
Full Text)
|
|
Ralte AM, Rao S, Sharma MC, Suri A, Gaikwad S, Sarkar
C
Myxopapillary ependymoma of the temporal lobe--report of
a rare case of temporal lobe epilepsy
Clin Neuropathol. 2004 Mar-Apr;23(2):53-8. (Case Report, Abstract)
|
|
|
Treatment
|
|
|
|
Benedetti S, Bruzzone MG, Pollo B, DiMeco F,
Magrassi L, Pirola B, Cirenei N, Colombo MP, Finocchiaro G
Eradication
of rat malignant gliomas by retroviral-mediated, in vivo delivery of the
interleukin 4 gene
Cancer Res. 1999
Feb 1;59(3):645-52.
|
|
Buklina SB
Impairments in
premorbid knowledge recall in patients with hemispheric and intraventricular
brain damage
Neurosci Behav Physiol. 2003 Nov;33(9):933-8.
|
|
M.
Raphael Pfeffer, Mark L. Levitt, Dan Aderka
Gefitinib
in Recurrent Glioblastoma
Journal of Clinical
Oncology, Vol 22, No 13 (July 1), 2004: pp. 2755.
|
|
Jeremy
N. Rich, Henry S. Friedman, James B. Powell, Jr,
Janet E. Dancey
In
Reply
Journal of Clinical
Oncology, Vol 22, No 13 (July 1), 2004: pp. 2755-a-2756.
|
|
Jeremy N. Rich, David
A. Reardon, Terry Peery, Jeannette M. Dowell,
Jennifer A. Quinn, Kara L. Penne, Carol J.
Wikstrand, Lauren B. Van Duyn, Janet E. Dancey,
Roger E. McLendon, James C. Kao, Timothy
T. Stenzel, B.K. Ahmed Rasheed, Sandra E.
Tourt-Uhlig, James E. Herndon, II, James J.
Vredenburgh, John H. Sampson, Allan H. Friedman,
Darell D. Bigner, Henry S. Friedman
Phase II Trial of Gefitinib in Recurrent
Glioblastoma
Journal of Clinical Oncology, Vol 22, No 1 (January 1), 2004: pp. 133-142
|
bottom
|